X
X

COVID-19:   We would like to inform our customers and partners that we are making every effort to ensure the continuity of our services during this time. We applied contingency plans to our production facilities, and — to date — our production is running under strict safety measures to protect the health of our staff. We will keep our customers informed as the situation evolves.

Convergence Platform

Convergence Platform

Introducing Convergence™, a new ethanol fermentation platform of high-performance yeast and enzymes united for greater value, efficiency and profitability. This revolutionary advancement features TransFerm® yeast technology genetically merged with a new, novel enzyme expression system capable of producing an enhanced glucoamylase within the yeast cell which virtually eliminates the need for external GA purchases.

 

 

TransFerm® CV5

New TransFerm CV5 represents the most advanced application of the Convergence platform.  In addition to the GA expression, TransFerm® CV5 still contains the highest yielding yeast technology in its glycerol reducing pathway designed to make fermentation more efficient and higher yielding compared to basic ethanol fermenting yeast. Fuel ethanol production facilities using TransFerm® CV5 may experience substantial improvement in fermentation performance for higher yields under stress conditions

View the product sheet

Alcolase™ 146

Alcolase™ 146 is a high performance glucoamylase blend.  It is developed to maximize the fermentation performance of TransFerm Cv5 and provide optimal results at significantly lower dose than other commercial enzyme blends.

View the product sheet

Bio-Ferm® EGA

Bio-Ferm® EGA is an advanced dry yeast strain of Saccharomyces cerevisiae expressing an enhanced glucoamylase enzyme (GA) used in the production of fuel ethanol from liquefied grains.

View the product sheet

« back to Convergence Platform

* Not all products are available in all markets nor associated claims allowed in all regions.